• Tofacitinib Citrate in Immune Research: Protocols & Pitfalls

  2026-05-24

  Tofacitinib citrate (CP-690550 citrate) enables precision immune modulation and JAK-STAT pathway dissection with nanomolar selectivity. This article translates recent endothelial findings and advanced workflows into actionable protocols and troubleshooting strategies for applied immunology and inflammatory disorder research.

• Fluorescein TSA Fluorescence System Kit: Amplifying Biomolec

  2026-05-23

  The Fluorescein TSA Fluorescence System Kit delivers unmatched sensitivity for detecting low-abundance targets in fixed cells and tissues, making it indispensable for advanced IHC, ICC, and ISH workflows. Integrating tyramide signal amplification with flexible protocol parameters, this kit from APExBIO enables high-resolution, reproducible outcomes across neurobiology and translational research.

• MLKL Polymerization Drives Lysosomal Membrane Permeabilizati

  2026-05-22

  This study elucidates how polymerization of MLKL leads to lysosomal membrane permeabilization (LMP), a critical event in necroptosis execution. The findings clarify the role of lysosomal cathepsin B release in mediating cell death, with implications for targeting necroptosis in disease models.

• Bifendate Inhibits Autophagy and Lipid Accumulation in Hepat

  2026-05-22

  The referenced study demonstrates that bifendate (DDB), a hepatoprotective agent, inhibits multiple steps of the autophagy pathway and reduces oleic acid-induced lipid droplet accumulation in vitro. These findings provide mechanistic insight into DDB's potential therapeutic action in hepatic lipid metabolism, with implications for research on non-alcoholic fatty liver disease.

• Accelerating Neurotherapeutic Discovery: FDA-Approved Librar

  2026-05-21

  Explore how the DiscoveryProbe™ FDA-approved Drug Library transforms drug discovery for neurodevelopmental disorders by enabling mechanistic screens, rapid repositioning, and translational insights. Drawing on recent breakthroughs in MeCP2-TBL1 interaction inhibition, this thought-leadership article offers strategic guidance for researchers aiming to bridge molecular pathology and therapeutic innovation.

• Repurposing Safe Drugs to Direct DNA Repair in CRISPR Editin

  2026-05-21

  This study systematically screened FDA-approved drugs to identify modulators of DNA double-strand break repair pathway choice in human stem cells during CRISPR editing. The findings enable programmable control over genome editing outcomes, supporting advances in disease modeling, gene therapy, and synthetic lethality strategies.

• Safe DNA Gel Stain: Sensitive, Safer DNA and RNA Gel Stainin

  2026-05-20

  Safe DNA Gel Stain offers high-sensitivity nucleic acid detection in agarose and acrylamide gels with reduced mutagenicity. This DNA and RNA gel stain enables visualization with blue-light excitation, lowering DNA damage and improving cloning efficiency compared to ethidium bromide.

• PPT (Propyl Pyrazole Triol): Precision Tools for ERα Signali

  2026-05-20

  PPT (Propyl Pyrazole Triol) empowers researchers with subtype-specific activation of estrogen receptor alpha, enabling rigorous dissection of ERα-mediated pathways in cancer and developmental models. This article delivers an applied, protocol-centric guide with troubleshooting insights grounded in recent biomarker and ceRNA network advances.

• Efficient iPSC Differentiation to Retinal Ganglion Cells via

  2026-05-19

  This study introduces a robust, chemically defined protocol for differentiating induced pluripotent stem cells (iPSCs) into functional retinal ganglion cells (RGCs) by concurrently inhibiting SMAD and Wnt pathways. The method significantly improves yield and reproducibility, addressing critical limitations in RGC generation for glaucoma and neurodegenerative disease research.

• JC-1 Mitochondrial Membrane Potential Assay Kit: Workflows &

  2026-05-19

  Unlock sensitive, reproducible assessment of mitochondrial health with the JC-1 Mitochondrial Membrane Potential Assay Kit. This guide details experimental best practices, advanced immunometabolic workflows, and troubleshooting strategies, drawing on recent research and practical lab experience.

• Brefeldin A (SKU B1400): Reproducible ER Stress & Apoptosis

  2026-05-18

  This article provides a scenario-driven, evidence-based guide for using Brefeldin A (SKU B1400) in cell viability, apoptosis, and protein trafficking assays. By addressing common laboratory challenges and comparing vendor quality, we demonstrate how Brefeldin A from APExBIO supports reproducible, interpretable results for advanced cell biology research.

• Cisplatin (CDDP): Applied Workflows and Troubleshooting in C

  2026-05-18

  Cisplatin (CDDP) remains a benchmark DNA crosslinking agent for apoptosis, tumor inhibition, and chemoresistance studies. This guide translates recent advances—including exosome rescue of granulosa cell apoptosis—into actionable protocols and troubleshooting strategies, empowering researchers to maximize reproducibility and insight.

• Bifendate Inhibits Autophagy and Reduces Lipid Droplet Accum

  2026-05-17

  This study elucidates how bifendate (DDB) disrupts multiple steps of the autophagy process and attenuates oleic acid-induced intracellular lipid droplet accumulation in vitro. The findings establish a mechanistic link between autophagy inhibition and hepatic lipid homeostasis, providing a foundation for future research into metabolic liver disease therapies.

• BGJ398 (NVP-BGJ398): Precision FGFR Inhibition in Translatio

  2026-05-16

  Explore how BGJ398 (NVP-BGJ398), a highly selective FGFR inhibitor, is revolutionizing FGFR-driven malignancies research. This article bridges new mechanistic insights—including developmental biology findings on Fgfr2—with actionable guidance for translational researchers. Gain strategic and practical recommendations for leveraging BGJ398 in experimental workflows, understand its competitive edge, and anticipate the next evolution in FGFR-targeted oncology.

• Safe DNA Gel Stain: Elevating DNA and RNA Gel Visualization

  2026-05-15

  Safe DNA Gel Stain from APExBIO revolutionizes DNA and RNA visualization workflows by offering high sensitivity, blue-light compatibility, and dramatically improved safety over traditional stains. This article details hands-on protocol enhancements, troubleshooting guidance, and the translational impact of adopting this less mutagenic, next-generation nucleic acid stain.

476 records 12/32 page Previous Next First page 上5页 1112131415 下5页 Last page